Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options

Open to people ages 18 years and up

• Male and female aged 18 or older whom have given informed consent
• Ability to comply with the protocol
• Females must be non lactating and not at risk of pregnancy
• Patients with invasive fungal disease
• Patients who have limited alternative treatment options

• Women who are pregnant or breast feeding
• Known history of allergy hypersensitivity to any study drug components
• Patients with chronic aspergillosis
• HIV patients who are not receiving antiretroviral therapy
• Previously enrolled patients or patients enrolled in any clinical trial within the last 30 days
• Patients with a medical condition that may jeopardize adherence to the protocol or may cause unacceptable additional risk to the patient
• Patients with predicted short survival time
• Prohibited concomitant medications